Press Releases
RSS feedMyology 2016 – Day 5: Focus on the heart and advanced therapies
The congress Myology 2016, organised by AFM-Téléthon, is now coming to an end: over 900 international experts in the field (researchers, clinicians, doctors…) have compared their latest work for 5 days. This edition was undoubtedly marked by the beginning of the therapeutic era for neuromuscular diseases with the presentation of clinical trials results in human … [Read more]
Myology 2016 – Day 4: Focus on therapeutics on trial
The fourth day of Myology 2016, organised by AFM-Téléthon, opened on a plenary session dedicated to the different myology-related advances. H. Lee Sweeney from the University of Florida (USA), co-chairman of the congress, overviewed the trials using oligonucleotides in Duchenne muscular dystrophy. He underlined the need, for demonstrating the efficiency of products currently under clinical … [Read more]
Focus Researcher: Jerry Mendell at Myology 2016
Jerry Mendell told us about gene therapy in spinal muscular atrophy.
Focus Researcher: H. Lee Sweeney at Myology 2016
H. Lee Sweeney discusses the difficulty of having drugs approved for Duchenne Muscular Dystrophy.
Focus Researcher : Ichizo Nishino at Myology 2016
Ichizo Nishino explains his successful results for Nonaka myopathy (GNE).
Myology 2016 – Day 3: Focus on therapeutics on trial or being developed for neuromuscular diseases
Wednesday opened on a symposium based on the development of innovative therapies, which make a new, booming type of medicine. Because the first drug candidates developed so far are only “prototypes”, researchers and doctors are building a strategy to tackle the disease on all fronts. Matthew Wood from Oxford University (UK) restored the expression of … [Read more]
Focus researcher : Matthew Wood at Myology 2016
Matthew Wood discusses the challenges of developing gene therapy
Myology 2016 – Day 2 : Muscle biology and neuromuscular junction
Throughout this second day, Myology 2016 was the stage of plenary sessions focused on “Fundamental muscle biology and neuromuscular junction.” This second day started with a lecture by Christophe Marcelle, initially in charge of the Australian Regenerative Medicine Institute at the University Monash in Melbourne, which has carried out the project Muscle formation, growth and … [Read more]
Myology 2016 – Day 1: 30 years after the discovery of the gene involved in Duchenne muscular dystrophy, myology has become the backbone of therapeutic innovation
Myology 2016, the 5th international congress of myology, organised by AFM-Téléthon, has started yesterday. Throughout this week, over 800 international experts on muscle and its diseases will gather at the Palais des Congrès in Lyon. This event will be the highlight of international myology in 2016, 30 years after the discovery of the gene involved … [Read more]
Progeria: discovery of therapeutic approach at I-stem
Thanks to a screening, Xavier Nissan’s team of the Institute for Stem cell Therapy and Exploration of Monogenic diseases (I-stem) has identified a compound able to treat progeria, a rare genetic disease inducing premature aging. A world premiere. The study was conducted with sick induced pluripotent stem cells (or iPSCs). The adult cells “rejuvenated” acting … [Read more]
